var data={"title":"Neuromuscular manifestations of systemic sclerosis (scleroderma)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Neuromuscular manifestations of systemic sclerosis (scleroderma)</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/contributors\" class=\"contributor contributor_credentials\">Monica L Piecyk, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/contributors\" class=\"contributor contributor_credentials\">Peter H Schur, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/contributors\" class=\"contributor contributor_credentials\">John S Axford, DSc, MD, FRCP, FRCPCH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/contributors\" class=\"contributor contributor_credentials\">Monica Ramirez Curtis, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Aug 26, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The literature addressing neurologic involvement in systemic sclerosis (SSc; scleroderma) principally consists of case series and case reports. It includes the following categories, listed in approximate order of frequency:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cranial, entrapment, peripheral, cutaneous, autonomic neuropathies</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myopathy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central nervous system involvement, including headache, seizures, stroke, vascular disease, radiculopathy, and myelopathy</p><p/><p>In general, however, central nervous system (CNS) involvement due to SSc is rare, but complications of other organ damage may have neurologic manifestations. Examples include renal failure, uncontrolled hypertension, and heart or respiratory failure.</p><p>Estimates of the frequency of neurologic involvement in patients with SSc vary widely, ranging from 0 to 66 percent [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/1-7\" class=\"abstract_t\">1-7</a>]. Various forms of neurologic dysfunction have been described in association with diffuse, limited, and linear scleroderma. As an example, linear scleroderma en coup de sabre, which is characterized by a localized band of induration near the forehead, is occasionally associated with neurologic complications [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,9\" class=\"abstract_t\">8,9</a>]; headache, focal cerebral abnormalities, seizures, and stroke have also been described in affected children [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/10-13\" class=\"abstract_t\">10-13</a>]. (See <a href=\"topic.htm?path=localized-scleroderma-in-childhood\" class=\"medical medical_review\">&quot;Localized scleroderma in childhood&quot;</a>.)</p><p>An increased risk of neurologic involvement may be associated with the presence of anti-Scl-70 (anti-topoisomerase-I) and anti-U1-RNP; these antibodies are frequently found in patients with diffuse SSc and overlap syndromes, respectively [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/14\" class=\"abstract_t\">14</a>] (see <a href=\"topic.htm?path=anti-u1-rnp-antibodies-in-mixed-connective-tissue-disease\" class=\"medical medical_review\">&quot;Anti-U1 RNP antibodies in mixed connective tissue disease&quot;</a>). However, it appears unlikely that these autoantibodies are directly involved in the pathogenesis of neurologic injury.</p><p>In this topic review, the neurologic disorders that have been described in association with diffuse and limited forms of SSc are presented.</p><p>Neurologic disease in patients with SSc resulting from the consequences of hypertension, uremia, or pulmonary disease is discussed separately. (See <a href=\"topic.htm?path=moderate-to-severe-hypertensive-retinopathy-and-hypertensive-encephalopathy-in-adults\" class=\"medical medical_review\">&quot;Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-evaluation-and-diagnosis-of-interstitial-lung-disease-in-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">&quot;Clinical manifestations, evaluation, and diagnosis of interstitial lung disease in systemic sclerosis (scleroderma)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Diseases of the cranial and peripheral nerves and isolated cutaneous sensory branches have been described in association with systemic sclerosis (SSc; scleroderma). It is unknown whether neuropathy in patients with SSc is a primary or secondary event. Possible mechanisms include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vascular-dependent neuropathy, which is due to vasculitis <span class=\"nowrap\">and/or</span> vessel wall deterioration of the vasa nervorum.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Compression-dependent neuropathy, resulting from compression due to edema or fibrosis. This causes progressive demyelination.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autoimmune-dependent neuropathy (antineuronal antibodies) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/15,16\" class=\"abstract_t\">15,16</a>]. However, antibodies directed against a component of myelin do not correlate with peripheral neuropathy in patients with SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/17\" class=\"abstract_t\">17</a>].</p><p/><p/><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CRANIAL NEUROPATHIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many cranial neuropathies have been described in patients with systemic sclerosis (SSc; scleroderma). The most commonly involved is the trigeminal nerve, with dysfunction of the optic, oculomotor, trochlear, abducens, facial, glossopharyngeal, and auditory nerves also being reported [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/3-6,8,14,18-27\" class=\"abstract_t\">3-6,8,14,18-27</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Trigeminal neuropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Trigeminal neuropathy is the most common cranial nerve manifestation, occurring in 5 to 15 percent of patients in reported series [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/19,28\" class=\"abstract_t\">19,28</a>]. It may be the initial SSc manifestation [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/20,21,29-32\" class=\"abstract_t\">20,21,29-32</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Pathophysiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The underlying pathophysiology of trigeminal neuropathy in SSc patients is unknown. Electrophysiologic studies suggest that the site of disease is the gasserian ganglion [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,33\" class=\"abstract_t\">8,33</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Clinical manifestations and findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms include slowly progressive unilateral or bilateral facial numbness, frequently with associated pain (50 percent of patients) and paresthesia (60 percent) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,18,19,23,25,34\" class=\"abstract_t\">8,18,19,23,25,34</a>] (see <a href=\"topic.htm?path=trigeminal-neuralgia\" class=\"medical medical_review\">&quot;Trigeminal neuralgia&quot;</a>) The pain is usually burning in quality [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/23\" class=\"abstract_t\">23</a>]. Numbness is most common in the mandibular or maxillary divisions of the nerve, with symptoms in the cheek or around the mouth; the maximal deficit is usually reached after 6 to 24 months. Trigeminal motor function (muscles of mastication) usually is not affected.</p><p>Sensory loss is present upon physical examination. The corneal reflex is sometimes depressed or absent [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/34\" class=\"abstract_t\">34</a>]. (See <a href=\"topic.htm?path=the-detailed-neurologic-examination-in-adults\" class=\"medical medical_review\">&quot;The detailed neurologic examination in adults&quot;</a>.)</p><p>Pain is very common in SSc, affecting 83 percent of a Canadian registry of 585 patients: mild pain in 46 percent, moderate in 27 percent, and severe in 10 percent [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/35\" class=\"abstract_t\">35</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of isolated facial numbness is broad. It includes neuropathy associated with diabetes mellitus, sinus disease, multiple sclerosis, trauma, vertebrobasilar ischemia, and tumors of the brainstem, cerebellopontine angle, skull base, and nasopharynx [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The administration of glucocorticoids is probably not beneficial. In one series of 38 patients with connective tissue diseases (including some with SSc) and trigeminal neuropathy who were treated with <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a>, pain improved in two individuals, but facial numbness was unaffected [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/23\" class=\"abstract_t\">23</a>]. Chronic pain may require the use of analgesics, antidepressants, <span class=\"nowrap\">and/or</span> anticonvulsant medications, as utilized in a manner similar to that for patients with chronic neuropathic pain due to other etiologies. (See <a href=\"topic.htm?path=overview-of-the-treatment-of-chronic-non-cancer-pain\" class=\"medical medical_review\">&quot;Overview of the treatment of chronic non-cancer pain&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Other cranial neuropathies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As previously mentioned, sensory or motor deficits may occur with involvement of cranial nerves other than the trigeminal nerve. These include facial palsy, glossopharyngeal neuropathy, audiovestibular impairment, and optic neuropathy or neuritis [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/5,6,8,20,36-41\" class=\"abstract_t\">5,6,8,20,36-41</a>]. In addition, impaired extraocular muscle function may occur due to inflammatory ocular myopathy, restrictive ophthalmopathy, or cranial nerve IV or VI paresis [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,20,42-45\" class=\"abstract_t\">8,20,42-45</a>]. There is no evidence that any specific treatment is effective for these disorders in patients with SSc.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">ENTRAPMENT NEUROPATHIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common of the entrapment neuropathies is compression of the median nerve at the wrist or carpal tunnel syndrome (CTS). Nerves at other sites are less frequently involved.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Carpal tunnel syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Estimates of the frequency of CTS in patients with systemic sclerosis (SSc; scleroderma) vary from less than 5 to 25 percent [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/3,4,22,46-48\" class=\"abstract_t\">3,4,22,46-48</a>]. CTS sometimes presents prior to the diagnosis of limited [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/49\" class=\"abstract_t\">49</a>] or diffuse SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/47,49-53\" class=\"abstract_t\">47,49-53</a>]. The most likely pathologic mechanism is fibrosis leading to nerve entrapment. Rarely, calcific deposits may cause focal nerve compression [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/54-56\" class=\"abstract_t\">54-56</a>].</p><p>The clinical manifestations, diagnosis, and treatment of the patient with SSc and CTS are similar to those of the individual with the syndrome but without SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/57\" class=\"abstract_t\">57</a>]. (See <a href=\"topic.htm?path=carpal-tunnel-syndrome-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Carpal tunnel syndrome: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=carpal-tunnel-syndrome-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Carpal tunnel syndrome: Treatment and prognosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Other compressive neuropathies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ulnar neuropathy, posterior tibial neuropathy (tarsal tunnel syndrome), ilioinguinal nerve entrapment, and meralgia paresthetica also have been reported [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,46-48,54,58,59\" class=\"abstract_t\">4,46-48,54,58,59</a>]. Asymptomatic electrodiagnostic evidence of compression neuropathies may occur [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/5,46,48,60\" class=\"abstract_t\">5,46,48,60</a>].</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">PERIPHERAL POLYNEUROPATHIES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The peripheral polyneuropathies, consisting of sensory, mixed sensory and motor, and mononeuritis multiplex, are common in patients with diffuse systemic sclerosis (SSc; scleroderma) but are uncommon in those with limited disease [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/2-6,8,14,22,46,60-62\" class=\"abstract_t\">2-6,8,14,22,46,60-62</a>]. In one series of 536 patients with limited SSc, for example, only seven had a peripheral neuropathy not attributable to another cause [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/62\" class=\"abstract_t\">62</a>]. In another series of 60 SSc patients, 28 percent had clinical <span class=\"nowrap\">and/or</span> electrophysiologic evidence of peripheral neuropathy [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/63\" class=\"abstract_t\">63</a>]. However, most (82 percent) of these patients had another potential etiology for the neuropathy.</p><p>Excluding the entrapment neuropathies, a symmetric, sensory polyneuropathy is the neuropathy most frequently associated with SSc. Mononeuropathy or mononeuritis multiplex may occur as a manifestation of vasculitis and is more frequent in patients with limited SSc (the CREST syndrome [Calcinosis cutis Raynaud phenomenon Esophageal dysmotility Sclerodactyly Telangiectasia]) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/2-6,8,14,22,46,60-62\" class=\"abstract_t\">2-6,8,14,22,46,60-62</a>]. Because vasculitis is not a typical manifestation of SSc, another overlapping disease, such as systemic lupus erythematosus (SLE), or a concomitant disease, such as cryoglobulinemia [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/64\" class=\"abstract_t\">64</a>] due to hepatitis C infection, should be considered in this setting.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Pathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are few reports of peripheral nerve pathology in patients with SSc and neuropathy [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/15,65-67\" class=\"abstract_t\">15,65-67</a>]. Findings in biopsied nerves include [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,62,68,69\" class=\"abstract_t\">8,62,68,69</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased collagen and amorphous substance in the endoneurium</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Loss of myelinated fibers</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Intimal thickening, adventitial edema, and diffuse hyalinosis of endoneurial and perineurial blood vessels</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Necrotizing vasculitis (very rare)</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Types</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sensory polyneuropathy &ndash; As mentioned, a distal, symmetric, sensory axonal polyneuropathy is the most common type observed in patients with SSc. The significance of subtle neurophysiologic changes which have been observed in patients with no neurologic symptoms is unclear [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/3,5,8,60\" class=\"abstract_t\">3,5,8,60</a>]. Abnormal nerve conduction may occur at sites where there is no cutaneous sclerosis, suggesting a mechanism other than nerve compression [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/70\" class=\"abstract_t\">70</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mixed sensory and motor polyneuropathy &ndash; Sensorimotor polyneuropathy can also be observed. In one series of 50 patients with SSc, 14 percent had a sensorimotor polyneuropathy [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4\" class=\"abstract_t\">4</a>]. As with other neurologic manifestations, this abnormality may present prior to the diagnosis of SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,65,71,72\" class=\"abstract_t\">4,65,71,72</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mononeuritis multiplex &ndash; Rarely, infarction of peripheral nerves due to inflammation of the vasa nervorum may lead to mononeuritis multiplex [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/3,4,68,73,74\" class=\"abstract_t\">3,4,68,73,74</a>]. This vasculitic neuropathy may be more likely if the patient has both SSc and Sj&ouml;gren's syndrome [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/68\" class=\"abstract_t\">68</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-of-sjogrens-syndrome-extraglandular-disease\" class=\"medical medical_review\">&quot;Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-of-vasculitic-neuropathy\" class=\"medical medical_review\">&quot;Clinical manifestations of vasculitic neuropathy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Brachial plexopathy &ndash; Brachial plexopathy also has been reported in association with SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/75\" class=\"abstract_t\">75</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cutaneous neuropathies &ndash; Cutaneous neuropathies can develop in sclerodermatous or non-sclerodermatous areas of skin [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8\" class=\"abstract_t\">8</a>]. Tactile abnormalities are more common in the feet than in the hands and are more common at the fingertips than on the palms.</p><p/><p class=\"bulletIndent1\">Clinical manifestations of a cutaneous neuropathy may be observed despite the absence of objective abnormalities [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8\" class=\"abstract_t\">8</a>]; conversely, histologic evidence of damage can be seen upon examination of clinically uninvolved skin [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/76\" class=\"abstract_t\">76</a>].</p><p/><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Alternate etiologies should be considered in patients who develop clinical peripheral neuropathies. (See <a href=\"topic.htm?path=overview-of-polyneuropathy\" class=\"medical medical_review\">&quot;Overview of polyneuropathy&quot;</a>.) These include [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8\" class=\"abstract_t\">8</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alcoholism</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Renal failure</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diabetes mellitus</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Connective tissue diseases</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Paraneoplastic syndromes</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Paraproteinemia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HIV infection</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drug or environmental toxicities</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Familial neuropathies</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vitamin deficiency</p><p/><p>There are no specific findings on neurophysiologic studies that distinguish the peripheral neuropathy of SSc from other diseases. (See <a href=\"topic.htm?path=differential-diagnosis-of-peripheral-nerve-and-muscle-disease\" class=\"medical medical_review\">&quot;Differential diagnosis of peripheral nerve and muscle disease&quot;</a>.)</p><p>Vitamin B12 deficiency should be considered in patients with SSc of the intestine and resultant malabsorption.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Management of sensory and sensorimotor polyneuropathy in the patient with SSc that is not due to vasculitis or multiple nerve entrapments is similar to that of neuropathy in patients with other rheumatic diseases. If the polyneuropathy is associated with systemic vasculitis, <a href=\"topic.htm?path=cyclophosphamide-drug-information\" class=\"drug drug_general\">cyclophosphamide</a> and glucocorticoids are the usual initial regimen. (See <a href=\"topic.htm?path=overview-of-polyneuropathy#H17\" class=\"medical medical_review\">&quot;Overview of polyneuropathy&quot;, section on 'Management'</a> and <a href=\"topic.htm?path=initial-immunosuppressive-therapy-in-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis\" class=\"medical medical_review\">&quot;Initial immunosuppressive therapy in granulomatosis with polyangiitis and microscopic polyangiitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">AUTONOMIC NEUROPATHY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abnormal gastrointestinal motility in patients with systemic sclerosis (SSc; scleroderma) is due in part to autonomic dysfunction [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/16,77-79\" class=\"abstract_t\">16,77-79</a>] (see <a href=\"topic.htm?path=gastrointestinal-manifestations-of-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">&quot;Gastrointestinal manifestations of systemic sclerosis (scleroderma)&quot;</a>). Autonomic dysfunction also possibly contributes to impotence, which occurs frequently in SSc patients [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,80-82\" class=\"abstract_t\">8,80-82</a>].</p><p>Laboratory evidence of sympathetic and parasympathetic dysfunction of cardiovascular reflexes is also common and may lead to headaches [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/83\" class=\"abstract_t\">83</a>]; however, this is rarely clinically significant [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8,84-87\" class=\"abstract_t\">8,84-87</a>]. In addition, an abnormal or absent sympathetic skin response has been demonstrated [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/60,88\" class=\"abstract_t\">60,88</a>].</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h1\">MUSCLE WEAKNESS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A complaint of muscle weakness is quite common in those with systemic sclerosis (SSc; scleroderma), being reported in over 80 percent of patients [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/89,90\" class=\"abstract_t\">89,90</a>]. The areas most affected are frequently located in the vicinity of involved joints and skin, but this finding does not necessarily reflect underlying muscle disease. Nevertheless, both a myopathy and myositis have been observed. In addition, muscle weakness and atrophy may arise from disuse.</p><p>Cardiac involvement was more frequent in patients with skeletal muscle disease in a case-control study, which compared 40 SSc patients with myopathy (muscle weakness or myalgia associated with elevation of creatine kinase (CK) more than five times the upper limit of normal, myopathic changes on electromyography (EMG), or abnormal muscle pathology) with SSc patients without myopathy [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/91\" class=\"abstract_t\">91</a>]. Cardiac involvement, defined as arrhythmia or conduction abnormalities, clinical heart failure, or left ventricular ejection fraction less than 60, was more common in the patients with myositis (odds ratio 2.9).</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Myopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A mild, indolent type of proximal myopathy has been described in patients with SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,5,14,20,92\" class=\"abstract_t\">4,5,14,20,92</a>]. It is associated with the following laboratory and diagnostic test results [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,89,93\" class=\"abstract_t\">4,89,93</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Insignificant elevations in the CK levels</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased duration of motor unit potential on EMG</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased frequency of polyphasic motor units</p><p/><p>Muscle biopsy specimens reveal mild abnormalities, including increased connective tissue, proliferation of intima in endomysial and perimysial blood vessels, and occasional perivascular infiltrates [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/92,94,95\" class=\"abstract_t\">92,94,95</a>].</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Management</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The indolent proximal type of myopathy is usually nonprogressive; immunosuppressive therapy is ineffective and is not indicated [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4\" class=\"abstract_t\">4</a>].</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Myositis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with SSc may develop an inflammatory myopathy clinically and histologically similar to classic polymyositis [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,5,8,89,92,95\" class=\"abstract_t\">4,5,8,89,92,95</a>]. This should be suspected if any of the following features are present:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Weakness is progressive or severe</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>CK level is over twice normal</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>EMG studies reveal abnormalities suggestive of myositis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Muscle involvement can also be demonstrated by magnetic resonance imaging (MRI) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/96,97\" class=\"abstract_t\">96,97</a>]</p><p/><p>The diagnosis is confirmed by muscle biopsy. Inclusion body myositis is rarely reported in association with SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4\" class=\"abstract_t\">4</a>]. Some of these patients develop myofibrosis [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/92\" class=\"abstract_t\">92</a>]. The presence of fibrosis is associated with anti-PM-Scl antibodies [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/98\" class=\"abstract_t\">98</a>].</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h3\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Therapy is similar to that of classic polymyositis; this includes glucocorticoids with or without cytotoxic agents [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,5\" class=\"abstract_t\">4,5</a>]. Patients should also be evaluated for possible cardiac involvement (see <a href=\"topic.htm?path=initial-treatment-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">&quot;Initial treatment of dermatomyositis and polymyositis in adults&quot;</a> and <a href=\"#H19\" class=\"local\">'Muscle weakness'</a> above). In a large Canadian cohort of SSc patients, mortality was increased for those with an elevated CK [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/99\" class=\"abstract_t\">99</a>].</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Drug-induced muscle disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Drug-induced muscle disease is a consideration in patients with SSc whose weakness develops in conjunction with therapeutic use of agents known to cause myopathy, myositis, or neuromuscular junction disease (see below). Among the offending agents are statins, D-penicillamine, glucocorticoids, <a href=\"topic.htm?path=colchicine-drug-information\" class=\"drug drug_general\">colchicine</a> and antimalarial drugs. (See <a href=\"topic.htm?path=drug-induced-myopathies\" class=\"medical medical_review\">&quot;Drug-induced myopathies&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Neuromuscular junction dysfunction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The co-occurrence of SSc and myasthenia gravis, in the absence of drugs that can cause neuromuscular junction dysfunction, has been reported in a small number of patients. In a report of two cases and a review of 12 others, the overwhelming majority were women, and most had seropositive myasthenia gravis (ie, positive serum antibodies to either the acetylcholine receptor [AChR] or to muscle tyrosine kinase [MuSk]) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/100\" class=\"abstract_t\">100</a>]. (See <a href=\"topic.htm?path=diagnosis-of-myasthenia-gravis\" class=\"medical medical_review\">&quot;Diagnosis of myasthenia gravis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h1\">CENTRAL NERVOUS SYSTEM INVOLVEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Reported central nervous system (CNS) manifestations of systemic sclerosis (SSc; scleroderma) range in severity from annoying (such as headache and radiculopathy) to life-threatening (including seizures, stroke, vasculitis, and myelopathy). Serious abnormalities are relatively rare.</p><p>However, these features may only be associations and may not directly result from pathogenic mechanisms unique to SSc. In autopsy studies, for example, evidence of brain injury or ischemia occurred in similar proportions in both patients and controls [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/94,101\" class=\"abstract_t\">94,101</a>].</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h2\">Headache</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>It is unclear whether there is an increased prevalence of migraine headache in patients with SSc. In one study of 36 SSc patients and 26 control individuals, an enhanced incidence of migraine headaches was reported in SSc patients (32 and 11 percent) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/102\" class=\"abstract_t\">102</a>]. However, an earlier study failed to find an association [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/103\" class=\"abstract_t\">103</a>]. Headache is treated in a similar fashion as that for patients without SSc, with the exception that ergot alkaloids and other vasoconstricting drugs are avoided.</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Seizures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are case reports of patients with both SSc and seizures; however, no clear evidence for a unifying pathogenesis exists [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/6,104,105\" class=\"abstract_t\">6,104,105</a>]. In a series of 155 SSc patients, 5 had generalized or focal seizures, which were most likely due to systemic complications of SSc (such as malignant hypertension and uremia) [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/2\" class=\"abstract_t\">2</a>]. In another series of 727 patients, 6 had seizures, an incidence similar to that in the general population [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H29\"><span class=\"h2\">Stroke</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A direct causal relationship between SSc and stroke has also not been adequately demonstrated. Ischemic and hemorrhagic infarcts have been reported in patients with both diffuse and limited SSc [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,39,106-110\" class=\"abstract_t\">4,39,106-110</a>]. In most cases, strokes were due to an atherosclerotic or hypertensive mechanism rather than directly due to SSc.</p><p class=\"headingAnchor\" id=\"H30\"><span class=\"h3\">Pathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pathologic findings associated with stroke are present at approximately the same frequency at autopsy in SSc and non-scleroderma patients [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/94,101\" class=\"abstract_t\">94,101</a>]. The brain and cerebral vasculature reveal medial and intimal hyperplasia and fibrosis generally without inflammatory cell infiltrates, which is located in the carotid artery or in medium- or small-sized intracranial arteries and arterioles [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/8\" class=\"abstract_t\">8</a>].</p><p>However, cerebral arterial wall calcifications may be relatively specific for SSc, even in asymptomatic patients [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/111\" class=\"abstract_t\">111</a>]. In one study, a head CT was performed in 37 consecutive patients with SSc as well as in 74 controls [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/112\" class=\"abstract_t\">112</a>]. Intracerebral calcification was reported in 32 and 9 percent of SSc patients and controls, respectively.</p><p class=\"headingAnchor\" id=\"H31\"><span class=\"h2\">Central nervous system vasculitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Central nervous system vasculitis is a rare complication of SSc, with most patients diagnosed without a brain biopsy and solely on the basis of findings with cerebral angiography, an approach which leaves the diagnosis uncertain [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/106,109,110,113-115\" class=\"abstract_t\">106,109,110,113-115</a>]. Improvement has been observed with glucocorticoid, <a href=\"topic.htm?path=cyclophosphamide-drug-information\" class=\"drug drug_general\">cyclophosphamide</a>, or <a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a> therapy [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/110,113,114\" class=\"abstract_t\">110,113,114</a>]. If CNS vasculitis is strongly suggested angiographically or is confirmed by biopsy, treatment is the same as that for patients with isolated CNS vasculitis without SSc. (See <a href=\"topic.htm?path=primary-angiitis-of-the-central-nervous-system-in-adults\" class=\"medical medical_review\">&quot;Primary angiitis of the central nervous system in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H32\"><span class=\"h2\">Radiculopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In SSc, radiculopathy can be due to nerve root compression by vertebral destruction or epidural calcinosis [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/6,8\" class=\"abstract_t\">6,8</a>].</p><p class=\"headingAnchor\" id=\"H33\"><span class=\"h2\">Myelopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptoms of myelopathy among patients with SSc may include impaired vibratory sense, bandlike paresthesias, hyperreflexia, impotence, and quadriparesis [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4,116-120\" class=\"abstract_t\">4,116-120</a>]. Findings may present acutely or indolently. In two reported cases, a transverse myelopathy developed acutely and improved after therapy with glucocorticoids. One of these patients was also treated with <a href=\"topic.htm?path=cyclophosphamide-drug-information\" class=\"drug drug_general\">cyclophosphamide</a> [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/116,121\" class=\"abstract_t\">116,121</a>]. Rarely, spinal cord compression may occur due to calcinosis in the spinal epidural space [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/117,120,122,123\" class=\"abstract_t\">117,120,122,123</a>]. Both paraspinal and intraspinal calcinosis can occur and are usually asymptomatic, but they may cause changes including paraplegia and sensory deficits [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/124\" class=\"abstract_t\">124</a>].</p><p class=\"headingAnchor\" id=\"H34\"><span class=\"h2\">MRI abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although clinically significant CNS manifestations due to SSc are relatively rare, sensitive imaging techniques such as magnetic resonance imaging (MRI) may detect abnormalities in asymptomatic patients that are of uncertain clinical significance. This was illustrated by two studies that included a total of 51 patients and 53 healthy age and sex-matched controls [<a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/125,126\" class=\"abstract_t\">125,126</a>]. None of the patients had a history of CNS disease or symptoms to suggest CNS dysfunction. In the first report, hyperintense lesions located in white matter were significantly more numerous in patients than in controls. The number of regions of T2-weighted hyperintensity was not dependent upon age or disease duration. In the second report, there was no significant difference in white matter hyperintensities between patients and controls. However, patients with abnormal MRI findings were significantly younger than controls.</p><p>While the pathogenesis and clinical significance of regions of increased white-matter T2-weighted signal in asymptomatic patients are uncertain, the high prevalence suggests caution in making therapeutic decisions based on the presence or absence of similar &ldquo;lesions&rdquo; in patients with symptoms of CNS dysfunction.</p><p class=\"headingAnchor\" id=\"H26846911\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurologic involvement in systemic sclerosis (SSc; scleroderma) includes cranial, entrapment, peripheral, cutaneous, and autonomic neuropathies; myopathy; and central nervous system (CNS) involvement, including headache, seizures, stroke, vascular disease, radiculopathy, and myelopathy. Estimates of the frequency of neurologic involvement in patients with SSc vary widely, but CNS involvement due to SSc is rare. Complications of other organ damage in SSc, such as renal failure, uncontrolled hypertension, and heart or respiratory failure, may have neurologic manifestations. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Possible mechanisms of neuropathy in SSc include vascular, compression-dependent, and autoimmune processes. (See <a href=\"#H2\" class=\"local\">'Pathophysiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Many cranial neuropathies have been described in patients with SSc. The most commonly involved is the trigeminal nerve, with dysfunction of the optic, oculomotor, trochlear, abducens, facial, glossopharyngeal, and auditory nerves also being reported. Symptoms of trigeminal neuropathy include slowly progressive unilateral or bilateral facial numbness, frequently with associated pain and paresthesia. However, the differential diagnosis of isolated facial numbness is broad. In trigeminal neuropathy, the administration of glucocorticoids is probably not beneficial. (See <a href=\"#H3\" class=\"local\">'Cranial neuropathies'</a> above and <a href=\"#H4\" class=\"local\">'Trigeminal neuropathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common of the entrapment neuropathies is compression of the median nerve at the wrist or carpal tunnel syndrome. Nerves at other sites are less frequently involved. CTS sometimes presents prior to the diagnosis of limited or diffuse SSc. (See <a href=\"#H10\" class=\"local\">'Entrapment neuropathies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The peripheral polyneuropathies, consisting of sensory, mixed sensory and motor, and mononeuritis multiplex, are common in patients with diffuse SSc but are uncommon in those with limited disease. Excluding the entrapment neuropathies, a symmetric, sensory polyneuropathy is the neuropathy most frequently associated with SSc. Mononeuropathy or mononeuritis multiplex may occur as a manifestation of vasculitis and is more frequent in patients with limited SSc. Because vasculitis is not a typical manifestation of SSc, another overlapping disease, such as systemic lupus erythematosus, or a concomitant disease, such as cryoglobulinemia due to hepatitis C infection, should be considered in this setting. (See <a href=\"#H13\" class=\"local\">'Peripheral polyneuropathies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abnormal gastrointestinal motility in patients with SSc is due, in part, to autonomic dysfunction. Autonomic dysfunction also possibly contributes to impotence, which occurs frequently in SSc patients. (See <a href=\"#H18\" class=\"local\">'Autonomic neuropathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A complaint of muscle weakness is quite common in those with SSc, being reported in over 80 percent of patients. The areas most affected are frequently located in the vicinity of involved joints and skin, but this finding does not necessarily reflect underlying muscle disease. Both a myopathy and myositis have been observed. An increased frequency of cardiac disease has been reported in association with SSc-related myositis. In addition, muscle weakness and atrophy may arise from disuse. (See <a href=\"#H19\" class=\"local\">'Muscle weakness'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reported CNS manifestations of SSc range in severity from annoying (such as headache and radiculopathy) to life-threatening (including seizures, stroke, vasculitis, and myelopathy). Serious abnormalities are relatively rare. However, these features may only be associations and may not directly result from pathogenic mechanisms unique to SSc. In autopsy studies, for example, evidence of brain injury or ischemia occurred in similar proportions in both patients and controls. (See <a href=\"#H26\" class=\"local\">'Central nervous system involvement'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/1\" class=\"nounderline abstract_t\">TUFFANELLI DL, WINKELMANN RK. Systemic scleroderma, A clinical study of 727 cases. Arch Dermatol 1961; 84:359.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/2\" class=\"nounderline abstract_t\">Gordon RM, Silverstein A. Neurologic manifstations in progressive systemic sclerosis. Arch Neurol 1970; 22:126.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/3\" class=\"nounderline abstract_t\">Lee P, Bruni J, Sukenik S. Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 1984; 11:480.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/4\" class=\"nounderline abstract_t\">Averbuch-Heller L, Steiner I, Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992; 49:1292.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/5\" class=\"nounderline abstract_t\">Hietaharju A, J&auml;&auml;skel&auml;inen S, Kalimo H, Hietarinta M. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve 1993; 16:1204.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/6\" class=\"nounderline abstract_t\">Hietaharju A, J&auml;ntti V, Korpela M, Frey H. Nervous system involvement in systemic lupus erythematosus, Sj&ouml;gren syndrome and scleroderma. Acta Neurol Scand 1993; 88:299.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/7\" class=\"nounderline abstract_t\">Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 2005; 52:2873.</a></li><li class=\"breakAll\">Rosenbaum RB, Campbell SM, Rosenbaum JT. Clinical Neurology of Rheumatic Diseases, Butterworth-Heinemann, Boston 1996.</li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/9\" class=\"nounderline abstract_t\">Holland KE, Steffes B, Nocton JJ, et al. Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics 2006; 117:e132.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/10\" class=\"nounderline abstract_t\">Chung MH, Sum J, Morrell MJ, Horoupian DS. Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol 1995; 37:679.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/11\" class=\"nounderline abstract_t\">David J, Wilson J, Woo P. Scleroderma 'en coup de sabre'. Ann Rheum Dis 1991; 50:260.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/12\" class=\"nounderline abstract_t\">Kanzato N, Matsuzaki T, Komine Y, et al. Localized scleroderma associated with progressing ischemic stroke. J Neurol Sci 1999; 163:86.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/13\" class=\"nounderline abstract_t\">Polcari I, Moon A, Mathes EF, et al. Headaches as a presenting symptom of linear morphea en coup de sabre. Pediatrics 2014; 134:e1715.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/14\" class=\"nounderline abstract_t\">Hietarinta M, Lassila O, Hietaharju A. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma). Scand J Rheumatol 1994; 23:64.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/15\" class=\"nounderline abstract_t\">Di Trapani G, Tulli A, La Cara A, et al. Peripheral neuropathy in course of progressive systemic sclerosis. Light and ultrastructural study. Acta Neuropathol 1986; 72:103.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/16\" class=\"nounderline abstract_t\">Cerinic MM, Generini S, Pignone A, Casale R. The nervous system in systemic sclerosis (scleroderma). Clinical features and pathogenetic mechanisms. Rheum Dis Clin North Am 1996; 22:879.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/17\" class=\"nounderline abstract_t\">Zeballos RS, Fox RI, Cheresh DA, McPherson RA. Anti-glycosphingolipid autoantibodies in rheumatologic disorders. J Clin Lab Anal 1994; 8:378.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/18\" class=\"nounderline abstract_t\">Ashworth B, Tait GB. Trigeminal neuropathy in connective tissue disease. Neurology 1971; 21:609.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/19\" class=\"nounderline abstract_t\">Farrell DA, Medsger TA Jr. Trigeminal neuropathy in progressive systemic sclerosis. Am J Med 1982; 73:57.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/20\" class=\"nounderline abstract_t\">Teasdall RD, Frayha RA, Shulman LE. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore) 1980; 59:149.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/21\" class=\"nounderline abstract_t\">Beighton P, Gumpel JM, Cornes NG. Prodromal trigeminal sensory neuropathy in progressive systemic sclerosis. Ann Rheum Dis 1968; 27:367.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/22\" class=\"nounderline abstract_t\">Berth-Jones J, Coates PA, Graham-Brown RA, Burns DA. Neurological complications of systemic sclerosis--a report of three cases and review of the literature. Clin Exp Dermatol 1990; 15:91.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/23\" class=\"nounderline abstract_t\">Hagen NA, Stevens JC, Michet CJ Jr. Trigeminal sensory neuropathy associated with connective tissue diseases. Neurology 1990; 40:891.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/24\" class=\"nounderline abstract_t\">Jimenez-Moreno J, Selva-O'Callaghan A, Rovira-Ca&ntilde;ellas A, et al. Trigeminal sensory neuropathy in systemic sclerosis. Br J Rheumatol 1998; 37:587.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/25\" class=\"nounderline abstract_t\">Lecky BR, Hughes RA, Murray NM. Trigeminal sensory neuropathy. A study of 22 cases. Brain 1987; 110 ( Pt 6):1463.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/26\" class=\"nounderline abstract_t\">Kabadi UM, Sinkoff MW. Trigeminal neuralgia in progressive systemic sclerosis. Postgrad Med 1977; 61:176.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/27\" class=\"nounderline abstract_t\">Tait B, Ashworth B. Trigeminal neuropathy in connective tissue disease. Ann Rheum Dis 1970; 29:339.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/28\" class=\"nounderline abstract_t\">Amaral TN, Peres FA, Lapa AT, et al. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum 2013; 43:335.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/29\" class=\"nounderline abstract_t\">Casey EB, Lawton NF. Progressive systemic sclerosis presenting with Raynaud's phenomenon in the tongue and sensory trigeminal neuropathy. Rheumatol Phys Med 1971; 11:131.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/30\" class=\"nounderline abstract_t\">Burke MJ, Carty JE. Trigeminal neuropathy as the presenting symptom of systemic sclerosis. Postgrad Med J 1979; 55:423.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/31\" class=\"nounderline abstract_t\">Heald A. Progressive systemic sclerosis presenting as a case of trigeminal neuropathy. J Neurol Neurosurg Psychiatry 1989; 52:918.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/32\" class=\"nounderline abstract_t\">Thompson PD, Robertson GJ. Trigeminal neuropathy heralding scleroderma. A report of a case. J Maine Med Assoc 1973; 64:123.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/33\" class=\"nounderline abstract_t\">Vicente A, Herrero C, Mart&iacute;n E, et al. Trigeminal sensory-neuropathy in systemic sclerosis. Clin Exp Dermatol 1991; 16:403.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/34\" class=\"nounderline abstract_t\">Olney RK. Neuropathies associated with connective tissue disease. Semin Neurol 1998; 18:63.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/35\" class=\"nounderline abstract_t\">Schieir O, Thombs BD, Hudson M, et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2010; 62:409.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/36\" class=\"nounderline abstract_t\">Berrettini S, Ferri C, Pitaro N, et al. Audiovestibular involvement in systemic sclerosis. ORL J Otorhinolaryngol Relat Spec 1994; 56:195.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/37\" class=\"nounderline abstract_t\">Amor-Dorado JC, Arias-Nu&ntilde;ez MC, Miranda-Filloy JA, et al. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore) 2008; 87:131.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/38\" class=\"nounderline abstract_t\">Boschi A, Snyers B, Lambert M. Bilateral optic neuropathy associated with the crest variant of scleroderma. Eur J Ophthalmol 1993; 3:219.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/39\" class=\"nounderline abstract_t\">Hietaharju A, J&auml;&auml;skel&auml;inen S, Hietarinta M, Frey H. Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand 1993; 87:382.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/40\" class=\"nounderline abstract_t\">Ortiz JR, Newman NJ, Barrow DL. CREST-associated multiple intracranial aneurysms and bilateral optic neuropathies. J Clin Neuroophthalmol 1991; 11:233.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/41\" class=\"nounderline abstract_t\">Trostle DC, Helfrich D, Medsger TA Jr. Systemic sclerosis (scleroderma) and multiple sclerosis. Arthritis Rheum 1986; 29:124.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/42\" class=\"nounderline abstract_t\">Arnett FC, Michels RG. Inflammatory ocular myopathy in systemic sclerosis (scleroderma). A case report and review of the literature. Arch Intern Med 1973; 132:740.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/43\" class=\"nounderline abstract_t\">Campbell WW, Bajandas FJ. Restrictive ophthalmopathy associated with linear scleroderma. J Neuroophthalmol 1995; 15:95.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/44\" class=\"nounderline abstract_t\">Mejias E. Superior oblique muscle paralysis in the CREST syndrome. P R Health Sci J 1986; 5:27.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/45\" class=\"nounderline abstract_t\">Rush JA. Isolated superior oblique paralysis in progressive systemic sclerosis. Ann Ophthalmol 1981; 13:217.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/46\" class=\"nounderline abstract_t\">Lori S, Matucci-Cerinic M, Casale R, et al. Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure. Clin Exp Rheumatol 1996; 14:601.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/47\" class=\"nounderline abstract_t\">Machet L, Vaillant L, Machet MC, et al. Carpal tunnel syndrome and systemic sclerosis. Dermatology 1992; 185:101.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/48\" class=\"nounderline abstract_t\">Mondelli M, Romano C, Della Porta PD, Rossi A. Electrophysiological evidence of &quot;nerve entrapment syndromes&quot; and subclinical peripheral neuropathy in progressive systemic sclerosis (scleroderma). J Neurol 1995; 242:185.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/49\" class=\"nounderline abstract_t\">Pal B. Carpal tunnel syndrome as a herald of autoimmune rheumatic disorders. J R Soc Med 1997; 90:216.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/50\" class=\"nounderline abstract_t\">Barr WG, Blair SJ. Carpal tunnel syndrome as the initial manifestation of scleroderma. J Hand Surg Am 1988; 13:366.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/51\" class=\"nounderline abstract_t\">Gonz&aacute;lez-Alvaro I, Carvajal I, Estevez M, et al. Carpal tunnel syndrome as initial manifestation of inflammatory connective tissue diseases. Ann Rheum Dis 1995; 54:782.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/52\" class=\"nounderline abstract_t\">Quinones CA, Perry HO, Rushton JG. Carpal tunnel syndrome in dermatomyositis and scleroderma. Arch Dermatol 1966; 94:20.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/53\" class=\"nounderline abstract_t\">Sukenik S, Abarbanel JM, Buskila D, et al. Impotence, carpal tunnel syndrome and peripheral neuropathy as presenting symptoms in progressive systemic sclerosis. J Rheumatol 1987; 14:641.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/54\" class=\"nounderline abstract_t\">Thurman RT, Jindal P, Wolff TW. Ulnar nerve compression in Guyon's canal caused by calcinosis in scleroderma. J Hand Surg Am 1991; 16:739.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/55\" class=\"nounderline abstract_t\">Chammas M, Meyer zu Reckendorf G, Allieu Y. Compression of the ulnar nerve in Guyon's canal by pseudotumoral calcinosis in systemic scleroderma. J Hand Surg Br 1995; 20:794.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/56\" class=\"nounderline abstract_t\">Polio JL, Stern PJ. Digital nerve calcification in CREST syndrome. J Hand Surg Am 1989; 14:201.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/57\" class=\"nounderline abstract_t\">Tagliafico A, Panico N, Resmini E, et al. The role of ultrasound imaging in the evaluation of peripheral nerve in systemic sclerosis (scleroderma). Eur J Radiol 2011; 77:377.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/58\" class=\"nounderline abstract_t\">Kaufmann J, Canoso JJ. Progressive systemic sclerosis and meralgia paraesthetica. Ann Intern Med 1986; 105:973.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/59\" class=\"nounderline abstract_t\">Langevitz P, Buskila D, Lee P. Ilioinguinal nerve entrapment in a patient with systemic sclerosis (scleroderma). Clin Rheumatol 1993; 12:540.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/60\" class=\"nounderline abstract_t\">Schady W, Sheard A, Hassell A, et al. Peripheral nerve dysfunction in scleroderma. Q J Med 1991; 80:661.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/61\" class=\"nounderline abstract_t\">Dierckx RA, Aichner F, Gerstenbrand F, Fritsch P. Progressive systemic sclerosis and nervous system involvement. A review of 14 cases. Eur Neurol 1987; 26:134.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/62\" class=\"nounderline abstract_t\">Dyck PJ, Hunder GG, Dyck PJ. A case-control and nerve biopsy study of CREST multiple mononeuropathy. Neurology 1997; 49:1641.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/63\" class=\"nounderline abstract_t\">Paik JJ, Mammen AL, Wigley FM, et al. Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma. Arthritis Care Res (Hoboken) 2016; 68:1150.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/64\" class=\"nounderline abstract_t\">Hurst RL, Berianu F, Ginsburg WW, et al. Cryoglobulinemic vasculitis in a patient with CREST syndrome. J Clin Neurosci 2014; 21:1821.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/65\" class=\"nounderline abstract_t\">Corbo M, Nemni R, Iannaccone S, et al. Peripheral neuropathy in scleroderma. Clin Neuropathol 1993; 12:63.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/66\" class=\"nounderline abstract_t\">Nitta Y, Sobue G. Progressive systemic sclerosis associated with multiple mononeuropathy. Dermatology 1996; 193:22.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/67\" class=\"nounderline abstract_t\">RICHTER RB. Peripheral neuropathy and connective tissue disease. J Neuropathol Exp Neurol 1954; 13:168.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/68\" class=\"nounderline abstract_t\">Oddis CV, Eisenbeis CH Jr, Reidbord HE, et al. Vasculitis in systemic sclerosis: association with Sj&ouml;gren's syndrome and the CREST syndrome variant. J Rheumatol 1987; 14:942.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/69\" class=\"nounderline abstract_t\">Said G, Lacroix-Ciaudo C, Fujimura H, et al. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol 1988; 23:461.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/70\" class=\"nounderline abstract_t\">Poncelet AN, Connolly MK. Peripheral neuropathy in scleroderma. Muscle Nerve 2003; 28:330.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/71\" class=\"nounderline abstract_t\">Knupp-Oliveira S, Cerinic MM. Polyneuropathy as initial manifestation of systemic sclerosis (scleroderma). Scand J Rheumatol 1999; 28:260.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/72\" class=\"nounderline abstract_t\">Sant SM, Murphy GM. Neurotropic ulceration in systemic sclerosis. Clin Exp Dermatol 1994; 19:65.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/73\" class=\"nounderline abstract_t\">Leichenko T, Herrick AL, Alani SM, et al. Mononeuritis in two patients with limited cutaneous systemic sclerosis. Br J Rheumatol 1994; 33:594.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/74\" class=\"nounderline abstract_t\">Goldsmith PC, Fowler CJ, Snaith ML, Dowd PM. Morphoea and mononeuritis multiplex. J R Soc Med 1991; 84:233.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/75\" class=\"nounderline abstract_t\">Allanore Y, Zuber M, Kahan A. Brachial plexopathy associated with systemic sclerosis. Clin Rheumatol 2002; 21:401.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/76\" class=\"nounderline abstract_t\">PAWLOWSKI A. THE NERVE NETWORK OF THE SKIN IN DIFFUSE SCLERODERMA AND CLINICALLY SIMILAR CONDITIONS. Arch Dermatol 1963; 88:868.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/77\" class=\"nounderline abstract_t\">Akesson A, Gustafson T, Wollheim F, Brismar J. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol 1987; 16:291.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/78\" class=\"nounderline abstract_t\">Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology 1989; 96:110.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/79\" class=\"nounderline abstract_t\">Lock G, Straub RH, Zeuner M, et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol 1998; 25:1330.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/80\" class=\"nounderline abstract_t\">Klein LE, Posner MS. Progressive systemic sclerosis and impotence. Ann Intern Med 1981; 95:658.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/81\" class=\"nounderline abstract_t\">Lally EV, Jimenez SA. Impotence in progressively systemic sclerosis. Ann Intern Med 1981; 95:150.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/82\" class=\"nounderline abstract_t\">Nowlin NS, Brick JE, Weaver DJ, et al. Impotence in scleroderma. Ann Intern Med 1986; 104:794.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/83\" class=\"nounderline abstract_t\">Dessein PH, Joffe BI, Metz RM, et al. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992; 93:143.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/84\" class=\"nounderline abstract_t\">Ferri C, Emdin M, Giuggioli D, et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol 1997; 36:669.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/85\" class=\"nounderline abstract_t\">Klimiuk PS, Taylor L, Baker RD, Jayson MI. Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 1988; 47:542.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/86\" class=\"nounderline abstract_t\">Sonnex C, Paice E, White AG. Autonomic neuropathy in systemic sclerosis: a case report and evaluation of six patients. Ann Rheum Dis 1986; 45:957.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/87\" class=\"nounderline abstract_t\">Straub RH, Zeuner M, Lock G, et al. Autonomic and sensorimotor neuropathy in patients with systemic lupus erythematosus and systemic sclerosis. J Rheumatol 1996; 23:87.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/88\" class=\"nounderline abstract_t\">Raszewa M, Hausmanowa-Petrusewicz I, B&#322;aszczyk M, Jab&#322;o&#324;ska S. Sympathetic skin response in scleroderma. Electromyogr Clin Neurophysiol 1991; 31:467.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/89\" class=\"nounderline abstract_t\">Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 1978; 21:62.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/90\" class=\"nounderline abstract_t\">Medsger TA Jr, Rodnan GP, Moossy J, Vester JW. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum 1968; 11:554.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/91\" class=\"nounderline abstract_t\">Ranque B, B&eacute;rezn&eacute; A, Le-Guern V, et al. Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features. Scand J Rheumatol 2010; 39:498.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/92\" class=\"nounderline abstract_t\">Brick JE, Brick JF. Neurologic manifestations of rheumatologic disease. Neurol Clin 1989; 7:629.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/93\" class=\"nounderline abstract_t\">Hausmanowa-Petrusewicz I, Jab&#322;o&#324;ska S, B&#322;aszczyk M, Matz B. Electromyographic findings in various forms of progressive systemic sclerosis. Arthritis Rheum 1982; 25:61.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/94\" class=\"nounderline abstract_t\">D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46:428.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/95\" class=\"nounderline abstract_t\">Ringel RA, Brick JE, Brick JF, et al. Muscle involvement in the scleroderma syndromes. Arch Intern Med 1990; 150:2550.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/96\" class=\"nounderline abstract_t\">Olsen NJ, King LE Jr, Park JH. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am 1996; 22:783.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/97\" class=\"nounderline abstract_t\">Paik JJ. Myopathy in scleroderma and in other connective tissue diseases. Curr Opin Rheumatol 2016; 28:631.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/98\" class=\"nounderline abstract_t\">Paik JJ, Wigley FM, Lloyd TE, et al. Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness. Arthritis Care Res (Hoboken) 2015; 67:1416.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/99\" class=\"nounderline abstract_t\">Jung M, Bonner A, Hudson M, et al. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort. Scand J Rheumatol 2014; 43:217.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/100\" class=\"nounderline abstract_t\">Zivkovi&#263; SA, Medsger TA Jr. Myasthenia gravis and scleroderma: two cases and a review of the literature. Clin Neurol Neurosurg 2007; 109:388.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/101\" class=\"nounderline abstract_t\">PIPER WN, HELWIG EB. Progressive systemic sclerosis; visceral manifestations in generalized scleroderma. AMA Arch Derm 1955; 72:535.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/102\" class=\"nounderline abstract_t\">Pal B, Gibson C, Passmore J, et al. A study of headaches and migraine in Sj&ouml;gren's syndrome and other rheumatic disorders. Ann Rheum Dis 1989; 48:312.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/103\" class=\"nounderline abstract_t\">Goldberg NC, Duncan SC, Winkelmann RK. Migraine and systemic scleroderma. Arch Dermatol 1978; 114:550.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/104\" class=\"nounderline abstract_t\">Bhardwaj A, Badesha PS. Seizures in a patient with diffuse scleroderma. Postgrad Med J 1995; 71:687.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/105\" class=\"nounderline abstract_t\">Pupillo G, Andermann F, Dubeau F. Linear scleroderma and intractable epilepsy: neuropathologic evidence for a chronic inflammatory process. Ann Neurol 1996; 39:277.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/106\" class=\"nounderline abstract_t\">Lee JE, Haynes JM. Carotid arteritis and cerebral infarction due to scleroderma. Neurology 1967; 17:18.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/107\" class=\"nounderline abstract_t\">Andonopoulos AP, Maraziotis T, Rigas G, et al. Multiple spontaneous intracerebral hemorrhages in a patient with progressive systemic sclerosis. Rev Rhum Engl Ed 1998; 65:437.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/108\" class=\"nounderline abstract_t\">Merino J, Casanueva B, Piney E, et al. Hemiplegia and peripheral gangrene secondary to large and medium size vessels involvement in C.R.E.S.T. syndrome. Clin Rheumatol 1982; 1:295.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/109\" class=\"nounderline abstract_t\">Miller SB, Lo HH, Campbell WG. Clinicopathologic conference. Grady Memorial Hospital--Emory University. Progressive systemic sclerosis with terminal neurologic manifestations. South Med J 1981; 74:735.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/110\" class=\"nounderline abstract_t\">Pathak R, Gabor AJ. Scleroderma and central nervous system vasculitis. Stroke 1991; 22:410.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/111\" class=\"nounderline abstract_t\">H&eacute;ron E, Fornes P, Rance A, et al. Brain involvement in scleroderma: two autopsy cases. Stroke 1998; 29:719.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/112\" class=\"nounderline abstract_t\">Heron E, Hernigou A, Chatellier G, et al. Intracerebral calcification in systemic sclerosis. Stroke 1999; 30:2183.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/113\" class=\"nounderline abstract_t\">Estey E, Lieberman A, Pinto R, et al. Cerebral arteritis in scleroderma. Stroke 1979; 10:595.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/114\" class=\"nounderline abstract_t\">Ishida K, Kamata T, Tsukagoshi H, Tanizaki Y. Progressive systemic sclerosis with CNS vasculitis and cyclosporin A therapy. J Neurol Neurosurg Psychiatry 1993; 56:720.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/115\" class=\"nounderline abstract_t\">Abers MS, Iluonakhamhe EK, Goldsmith CE, Kass JS. Central nervous system vasculitis secondary to systemic sclerosis. J Clin Neurosci 2013; 20:1168.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/116\" class=\"nounderline abstract_t\">Brown JJ, Murphy MJ. Transverse myelopathy in progressive systemic sclerosis. Ann Neurol 1985; 17:615.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/117\" class=\"nounderline abstract_t\">Bracard S, Thomas E, Braun M, et al. Cervical cord compression in scleroderma. One case. J Neuroradiol 1991; 18:12.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/118\" class=\"nounderline abstract_t\">Clement GB, Grizzard K, Vasey FB, et al. Neuropathic arthropathy (Charcot joints) due to cervical osteolysis: a complication of progressive systemic sclerosis. J Rheumatol 1984; 11:545.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/119\" class=\"nounderline abstract_t\">KAPLAN A, MATLES A. Compression of the thoracic spinal cord in a patient with scleroderma. Bull Hosp Joint Dis 1957; 18:98.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/120\" class=\"nounderline abstract_t\">Pinstein ML, Sebes JI, Leventhal M, Robertson JT. Case report 579: Progressive systemic sclerosis (PSS) with cervical cord compression syndrome, osteolysis and bilateral facet arthropathy. Skeletal Radiol 1989; 18:603.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/121\" class=\"nounderline abstract_t\">Franciotta D, Zardini E, Caporali R, et al. Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis. J Neurol Sci 2011; 303:139.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/122\" class=\"nounderline abstract_t\">Petrocelli AR, Bassett LW, Mirra J, et al. Scleroderma: dystrophic calcification with spinal cord compression. J Rheumatol 1988; 15:1733.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/123\" class=\"nounderline abstract_t\">Haverbush TJ, Wilde AH, Hawk WA Jr, Scherbel AL. Osteolysis of the ribs and cervical spine in progressive systemic sclerosis (scleroderma). A case report. J Bone Joint Surg Am 1974; 56:637.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/124\" class=\"nounderline abstract_t\">Ogawa T, Ogura T, Ogawa K, et al. Paraspinal and intraspinal calcinosis: frequent complications in patients with systemic sclerosis. Ann Rheum Dis 2009; 68:1655.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/125\" class=\"nounderline abstract_t\">Sardanelli F, Iozzelli A, Cotticelli B, et al. White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 2005; 64:777.</a></li><li><a href=\"https://www.uptodate.com/contents/neuromuscular-manifestations-of-systemic-sclerosis-scleroderma/abstract/126\" class=\"nounderline abstract_t\">Argyropoulou MI, Tsifetaki N, Zikou AK, et al. Systemic sclerosis: brain abnormalities revealed by conventional magnetic resonance imaging and magnetization transfer imaging. Arthritis Rheum 2006; 54:1350.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 7550 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H26846911\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CRANIAL NEUROPATHIES</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Trigeminal neuropathy</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Pathophysiology</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Clinical manifestations and findings</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Differential diagnosis</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Treatment</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">Other cranial neuropathies</a></li></ul></li><li><a href=\"#H10\" id=\"outline-link-H10\">ENTRAPMENT NEUROPATHIES</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">Carpal tunnel syndrome</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Other compressive neuropathies</a></li></ul></li><li><a href=\"#H13\" id=\"outline-link-H13\">PERIPHERAL POLYNEUROPATHIES</a><ul><li><a href=\"#H14\" id=\"outline-link-H14\">Pathology</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Types</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Differential diagnosis</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Treatment</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">AUTONOMIC NEUROPATHY</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">MUSCLE WEAKNESS</a><ul><li><a href=\"#H20\" id=\"outline-link-H20\">Myopathy</a><ul><li><a href=\"#H21\" id=\"outline-link-H21\">- Management</a></li></ul></li><li><a href=\"#H22\" id=\"outline-link-H22\">Myositis</a><ul><li><a href=\"#H23\" id=\"outline-link-H23\">- Treatment</a></li></ul></li><li><a href=\"#H24\" id=\"outline-link-H24\">Drug-induced muscle disease</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">Neuromuscular junction dysfunction</a></li></ul></li><li><a href=\"#H26\" id=\"outline-link-H26\">CENTRAL NERVOUS SYSTEM INVOLVEMENT</a><ul><li><a href=\"#H27\" id=\"outline-link-H27\">Headache</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">Seizures</a></li><li><a href=\"#H29\" id=\"outline-link-H29\">Stroke</a><ul><li><a href=\"#H30\" id=\"outline-link-H30\">- Pathology</a></li></ul></li><li><a href=\"#H31\" id=\"outline-link-H31\">Central nervous system vasculitis</a></li><li><a href=\"#H32\" id=\"outline-link-H32\">Radiculopathy</a></li><li><a href=\"#H33\" id=\"outline-link-H33\">Myelopathy</a></li><li><a href=\"#H34\" id=\"outline-link-H34\">MRI abnormalities</a></li></ul></li><li><a href=\"#H26846911\" id=\"outline-link-H26846911\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=anti-u1-rnp-antibodies-in-mixed-connective-tissue-disease\" class=\"medical medical_review\">Anti-U1 RNP antibodies in mixed connective tissue disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carpal-tunnel-syndrome-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Carpal tunnel syndrome: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carpal-tunnel-syndrome-treatment-and-prognosis\" class=\"medical medical_review\">Carpal tunnel syndrome: Treatment and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-sjogrens-syndrome-extraglandular-disease\" class=\"medical medical_review\">Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-vasculitic-neuropathy\" class=\"medical medical_review\">Clinical manifestations of vasculitic neuropathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-evaluation-and-diagnosis-of-interstitial-lung-disease-in-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">Clinical manifestations, evaluation, and diagnosis of interstitial lung disease in systemic sclerosis (scleroderma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-myasthenia-gravis\" class=\"medical medical_review\">Diagnosis of myasthenia gravis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=differential-diagnosis-of-peripheral-nerve-and-muscle-disease\" class=\"medical medical_review\">Differential diagnosis of peripheral nerve and muscle disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-induced-myopathies\" class=\"medical medical_review\">Drug-induced myopathies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastrointestinal-manifestations-of-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">Gastrointestinal manifestations of systemic sclerosis (scleroderma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-immunosuppressive-therapy-in-granulomatosis-with-polyangiitis-and-microscopic-polyangiitis\" class=\"medical medical_review\">Initial immunosuppressive therapy in granulomatosis with polyangiitis and microscopic polyangiitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-treatment-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">Initial treatment of dermatomyositis and polymyositis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=localized-scleroderma-in-childhood\" class=\"medical medical_review\">Localized scleroderma in childhood</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=moderate-to-severe-hypertensive-retinopathy-and-hypertensive-encephalopathy-in-adults\" class=\"medical medical_review\">Moderate to severe hypertensive retinopathy and hypertensive encephalopathy in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-polyneuropathy\" class=\"medical medical_review\">Overview of polyneuropathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-treatment-of-chronic-non-cancer-pain\" class=\"medical medical_review\">Overview of the treatment of chronic non-cancer pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-angiitis-of-the-central-nervous-system-in-adults\" class=\"medical medical_review\">Primary angiitis of the central nervous system in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-detailed-neurologic-examination-in-adults\" class=\"medical medical_review\">The detailed neurologic examination in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=trigeminal-neuralgia\" class=\"medical medical_review\">Trigeminal neuralgia</a></li></ul></div></div>","javascript":null}